RELMADA THERAPEUTICS, INC. Quarterly Common Stock, Shares Authorized from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Relmada Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q3 2012 to Q3 2024.
  • Relmada Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 150M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 150M 0 0% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 150M 0 0% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 150M 0 0% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 150M 0 0% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 150M 0 0% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 150M 0 0% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 150M +100M +200% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 150M 0 0% Dec 31, 2022 10-K 2024-03-19
Q3 2022 150M +100M +200% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 150M +100M +200% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 50M 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 150M +100M +200% Dec 31, 2021 10-K 2023-03-23
Q3 2021 50M 0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 50M 0 0% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 50M 0 0% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 50M 0 0% Dec 31, 2020 10-K 2022-03-25
Q3 2020 50M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 50M 0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 50M -150M -75% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 50M -50M -50% Dec 31, 2019 10-K 2021-03-24
Q3 2019 50M -50M -50% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 50M 0 0% Jun 30, 2019 10-K 2021-03-24
Q1 2019 200M +100M +100% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 100M 0 0% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 100M 0 0% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 50M -50M -50% Jun 30, 2018 10-KT 2020-03-26
Q1 2018 100M 0 0% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 100M 0 0% Dec 31, 2017 10-Q 2018-02-12
Q3 2017 100M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 100M 0 0% Jun 30, 2017 10-K 2018-09-28
Q1 2017 100M 0 0% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 100M 0 0% Dec 31, 2016 10-Q 2017-02-10
Q3 2016 100M 0 0% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 100M 0 0% Jun 30, 2016 10-K 2017-09-28
Q1 2016 100M -400M -80% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 100M -400M -80% Dec 31, 2015 10-Q 2016-02-05
Q3 2015 100M -400M -80% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 100M 0 0% Jun 30, 2015 10-K 2016-09-09
Q1 2015 500M -500M -50% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 500M 0 0% Dec 31, 2014 10-Q 2015-02-13
Q3 2014 500M +410M +456% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 100M +10M +11.1% Jun 30, 2014 10-K 2015-09-11
Q1 2014 1B +910M +1011% Mar 31, 2014 8-K 2014-05-27
Q4 2013 500M -500M -50% Dec 31, 2013 10-KT 2014-09-09
Q3 2013 90M 0 0% Aug 31, 2013 10-Q 2014-04-15
Q2 2013 90M May 31, 2013 10-Q 2013-07-12
Q1 2013 90M Feb 28, 2013 10-Q 2013-05-03
Q4 2012 1B Dec 31, 2012 8-K 2014-05-27
Q3 2012 90M Aug 31, 2012 10-K 2013-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.